Tempio

Test plan template for Fintech

Free download as CSV and Markdown. Nothing sits in front of the file: no form, no account, no email address.

The files

What it is

The test plan with three columns a regulated financial product needs: which product the test runs against, which claim the variant is putting under test, and the review reference that cleared both arms of it.

Everything else is the general test plan, unchanged. One hypothesis with a because in it, one variable, a named control, a minimum run, a read date set in advance and a decision rule for every outcome.

When to use it

Use it when a change to wording has to be cleared before it can be tried, which in this category is most of them. Naming the claim in the row is what lets the review happen once, before the build, rather than as a surprise after it.

Use it again to keep a record of which claims have been tested and which were refused, so the same idea is not proposed every year.

Every field, and what belongs in it
TypeHow to fill it
Test IDTextA short stable identifier that travels onto the creative file, the ad name and the review record, so a finding can be tied to the wording that was cleared for it.
HypothesisTextWhat you believe and why, with a because in it, and here the reason is usually about applicant quality: leading with the fee position will raise funded accounts because the current ad attracts people who do not qualify.
VariableTextThe single thing being changed, and in this category it is almost always a claim. Two claims in one variant means a review that clears both and a result that explains neither.
ControlTextWhat the variant is compared against, named exactly, including its review reference and the page it points at. A control whose page has drifted is not the control that was agreed.
VariantTextWhat is being tried, described so somebody could build it, and written as the exact claim that will go to review rather than as a paraphrase of it.
AudienceTextWho sees the test, identical on both sides and inside the same authorised market. A test whose arms deliver differently across markets is not comparable and may not be permissible.
Where it runsTextThe platform, campaign and placement the test lives in, and whether the placement can carry the disclosure the variant's claim requires at a readable size.
Primary metricTextThe one number this test is decided on, which should be a funded account or an approved application. A test read on applications will adopt whichever variant attracts people who are declined.
Minimum runTextThe shortest run before anybody looks, long enough for funded outcomes to land rather than for applications to accumulate, which makes tests here slower by construction.
Read dateDate (YYYY-MM-DD)The day the result is read, set in advance and after funded accounts from both arms have settled. Reading early answers a different question confidently.
Decision ruleTextWhat each outcome means, written before the test starts, including what happens when the variant lowers cost per application and lowers the approval rate with it.
OwnerTextThe person who builds the test, reads it on the read date, and records a refused claim as a result rather than dropping the row.
ResultTextWhat happened and what was decided, written on the read date, including a claim that review refused or narrowed before the test could run. Blank until then.
ProductTextThe financial product this test runs against. Approval and funding rates differ by product, so a result from one rarely transfers to another without being re-read.
Claim under testTextThe claim the variant is making, written plainly. It is what goes to review, and naming it here is what turns a review into an hour rather than a round of rework.
Review referenceTextThe reference that cleared both arms of this test, with its date. A test whose variant is not cleared cannot start, whatever the hypothesis is worth.

The claim is the variable, and it has to be cleared first

In most categories a test begins with an idea and ends with a build. Here it begins with an idea, goes through a review, and only then becomes a build. A plan that does not reflect that order will keep producing tests that are finished, unreviewable and stuck.

The claim under test column is what fixes it. Write the claim the variant makes in plain words — a fee position, a speed, an eligibility, a comparison — and send that sentence to review before anybody designs anything. Reviewing a sentence takes an hour. Reviewing a finished campaign takes a round of rework, and the rework happens after the test was supposed to start.

Both arms need a reference, not just the variant. The control is usually already cleared, but a test that changes where a claim sits, or what surrounds it, can change what the control is claiming too.

Refusals are findings worth keeping

When a claim is refused, the row does not disappear. It is recorded as refused, with the date and the reason.

That is a genuine finding about the product, and it is the kind most often lost. Without the record, the same idea is proposed every year by somebody new, spends another review cycle, and is refused again for the same reason. With it, a marketer can read what this product has been allowed to say and what it has not, which is the most practical guide available anywhere.

Keep those rows alongside the ones that ran. A test plan in this category is partly a test record and partly a claims history, and the second half is the one that compounds.

Test on the event the business counts

The most expensive mistake available here is testing on applications.

A variant can reliably lower the cost per application by promising more, or by reaching people who are further from qualifying. The applications arrive, the cost looks excellent, and the approval rate falls by more than the cost improved. In a plan that reads on applications a week after launch, that is a clear win and it will be adopted across the account.

So the primary metric should be a funded account or an approved application, and the read date has to allow time for those to land. Tests here are slower than in other categories for a structural reason, and shortening them does not make them faster, it makes them wrong.

Where the hypothesis is specifically about applicant quality, approval rate can be the metric. Be careful with volume: a rate calculated from a small number of applications moves enough to justify any conclusion.

One product, because the economics do not transfer

The product column exists because a finding rarely travels between an account, a card and a loan.

The audiences differ, the approval rates differ, and the reasons somebody abandons an application differ. A hook that works for a low-commitment product may perform badly for one that requires a credit decision, and the reverse is also true. Recording the product in the row is what stops a single good result being rolled out across a portfolio where it does not apply.

Both arms, same page, same disclosure

The landing page is a frequent invisible variable here, because a claim usually has an obligation attached to it.

If the variant's claim requires a different disclosure, the page changes, and the test is then measuring the page as much as the ad. Sometimes that is the intended test. Often it is not, and nobody noticed.

Write in the notes which page each arm points at and what disclosure it carries. Where the pages differ, say so plainly and treat the row as a test of the pair rather than of the headline.

Retargeting arms need a separate rule

Where a test includes a retargeting arm, note that the audience is made of people who began an application, which is an audience defined by a financial circumstance.

What may be said to it is narrower than what may be said to a cold audience, which means a variant cleared for prospecting is not automatically cleared here. Give the retargeting arm its own review reference, or keep it out of the test.

Volume, and what is worth testing at all

Application volumes in this category are often large enough to test properly, which is a genuine advantage over most regulated industries. Funded-account volumes usually are not.

That gap decides what is worth a row. Tests whose effect should be visible in applications — a headline, a landing page, an audience — can be read reasonably quickly. Tests whose effect is on who qualifies, which is the more valuable question, need a longer run and a larger sample, and shortening them produces the confident nonsense this plan exists to avoid.

The practical rule is to test fewer, larger things and to give them time. A plan with four well-run rows a quarter teaches more than one with twenty that were each read too early.

Seasonal and rate effects are confounds

Demand for a financial product moves with things that have nothing to do with advertising: a rate announcement, a competitor's promotion, the end of a financial year, a news story about the category.

Run both arms simultaneously so that whatever moves in the market moves under both, and write into the notes anything that happened during the run. At the read date those events are the alternative explanations for the result, and nobody will recall them a month later.

Sequential tests, where the variant runs after the control, should be treated as changes rather than tests. Too much sits in the gap between them.

Before you start the test

Every row has a hypothesis with a because in it. Every row names the claim the variant makes, in plain words, and both arms carry a review reference with a date. The primary metric is a funded account or an approved application. The read date allows those to land. The decision rule covers the outcome where nothing moves. And refused claims are recorded as rows too, with the date and the reason, because that record is the most useful half of this document.

The general template, and other industries

Templates that go with it

Related reading

Questions

Put frontier AI to work on every ad account you run.

Tempio connects your ad accounts into one workspace and hands your own AI the numbers and the tools. Every change it writes is a draft until you approve it, or until a rule you wrote does.

Request early access
  • Read and draft by default. Approve is a separate permission you grant.